Therefore, heparin antimetastatic activity is likely mainly related to inhibition of coagulation, heparanase, and P-selectin interactions [46], avoiding cancer cell activation of the coagulation cascade to recruit a protective layer of platelets, and increase inflammation and angiogenesis [14]. Here, SELP is linked to cancer.